Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients: A Prospective Cohort Study

NCT06947707 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.

NCT NCT06947707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06947707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients: A Prospective Cohort Study
Lead sponsor
Xuanwu Hospital, Beijing
Phase
Observational
Overall status
Recruiting
Start date
April 10, 2025
Completion date
December 31, 2027
Enrollment
1,486 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant drugs, anticoagulant prophylaxis/therapy, anticoagulant therapy, anticoagulants and thrombotic disorders, anticoagulation treatment, anticoagulation with direct oral anticoagulants, anticoagulation with noac, cerebral venous thrombosis, noacs